Indication
Change in Bone Mineral Density
2 clinical trials
2 products
Clinical trial
A Phase 3, Multi-Center, Non-Comparative Study to Evaluate the Contraceptive Efficacy, Safety, and Tolerability of LPRI-CF113 Administered Orally for 13 Medication CyclesStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Product
DrospirenoneClinical trial
A Multicenter, Open-label, Controlled Study to Investigate the Effect of Either LF111 or Drospirenone Chewable Tablets on Bone Mineral Density in Adolescent and Adult Women in Comparison With Non-users of Hormonal Contraceptive MethodsStatus: Recruiting, Estimated PCD: 2026-07-01
Product
LF111